Day One Biopharmaceuticals Inc
DAWNLatest QuantConomy context for DAWN: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
Day One Biopharmaceuticals Inc
QuantConomy has a structured record for DAWN. More descriptive asset metadata will appear here when the platform record includes it.
- Symbol
- DAWN
- Name
- Day One Biopharmaceuticals Inc
- Coverage
- 3 market/data records
- Sources
- alpaca fmp alphavantage sec nasdaq
Recent signals for DAWN
Scored rows are pulled from the same signal API used by the digests.
| Signal | Direction | Score | Observed | Reason |
|---|---|---|---|---|
| earnings release | neutral | 40 | Jan 12, 12:00 AM | DAWN filed an earnings release (8-K Item 2.02 - Results of Operations and Financial Condition) on 2026-01-12. Release-event signal only: confirms results were published, not the figures vs. estimates (no surprise/guidance read). |
| earnings release | neutral | 40 | Feb 24, 12:00 AM | DAWN filed an earnings release (8-K Item 2.02 - Results of Operations and Financial Condition) on 2026-02-24. Release-event signal only: confirms results were published, not the figures vs. estimates (no surprise/guidance read). |
| agreement termination | very bearish | 100 | Apr 23, 12:55 PM | DAWN filed 8-K: Termination of Material Agreement, Acquisition or Disposition, Delisting Notice - 6 material events - [very strong very bearish signal] |
EARNINGS signals are experimental: currently limited to neutral pre-earnings calendar awareness (no transcript analysis).
Market coverage
| Market | Exchange | Source | Asset record |
|---|---|---|---|
| DAWN | NASDAQ | alpaca | Day One Biopharmaceuticals, Inc. Common Stock |
| DAWN | NASDAQ | fmp | Day One Biopharmaceuticals, Inc. |
| DAWN | NASDAQ | alphavantage | Day One Biopharmaceuticals Inc |
Recent insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Apr 23, 2026 | Bender Jeremy | CHIEF EXECUTIVE OFFICER | other | 204,643 | — | — | 4 on EDGAR |
| Apr 23, 2026 | Merendino Lauren | Chief Commercial Officer | other | 60,157 | — | — | 4 on EDGAR |
| Apr 23, 2026 | Dubow Adam | Gen Counsel & Secretary | other | 72,694 | — | — | 4 on EDGAR |
| Apr 23, 2026 | VASCONCELLES MICHAEL | Head of Research and Dev. | other | 4,397 | — | — | 4 on EDGAR |
| Apr 23, 2026 | Grossman William | Director | other | 66,660 | — | — | 4 on EDGAR |
| Apr 23, 2026 | Garland J. Scott | Director | other | 48,072 | — | — | 4 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Query DAWN context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access